{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T11:45:42Z","timestamp":1782906342928,"version":"3.54.5"},"reference-count":17,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2000,3,1]],"date-time":"2000-03-01T00:00:00Z","timestamp":951868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2000,3]]},"DOI":"10.1016\/s0145-2126(99)00148-4","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T18:34:50Z","timestamp":1027622090000},"page":"183-187","source":"Crossref","is-referenced-by-count":21,"title":["A phase II study of high dose ARA-C and mitoxantrone for treatment of relapsed or refractory adult acute lymphoblastic leukemia"],"prefix":"10.1016","volume":"24","author":[{"given":"Peter J.","family":"Rosen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathryn","family":"Rankin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Head","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Boldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick W.","family":"Luthardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Norwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reginald P.","family":"Pugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chatchada","family":"Karanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick R.","family":"Appelbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S0145-2126(99)00148-4_BIB1","first-page":"27","article-title":"Acute lymphoblastic leukemia in adults: recent progress, future directions","volume":"24","author":"Hoelzer","year":"1987","journal-title":"Seminars. Hematol."},{"issue":"3","key":"10.1016\/S0145-2126(99)00148-4_BIB2","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1200\/JCO.1987.5.3.371","article-title":"A new regimen of amsacrine with high-dose cytarabine is safe and effective therapy for acute leukemia","volume":"5","author":"Arlin","year":"1987","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/S0145-2126(99)00148-4_BIB3","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1182\/blood.V72.2.433.bloodjournal722433","article-title":"Amsacrine with high-dose cytarabine is highly effective therapy for refractory and relapsed acute lymphoblastic leukemia in adults","volume":"72","author":"Arlin","year":"1988","journal-title":"Blood"},{"issue":"8","key":"10.1016\/S0145-2126(99)00148-4_BIB4","first-page":"712","article-title":"Short course high dose mitoxantrone with high dose cytarabine is effective therapy for adult lymphoblastic leukemia","volume":"5","author":"Arlin","year":"1991","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/S0145-2126(99)00148-4_BIB5","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1200\/JCO.1990.8.5.813","article-title":"Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia","volume":"8","author":"Cheson","year":"1990","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/S0145-2126(99)00148-4_BIB6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00944177","article-title":"Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria","volume":"10","author":"Green","year":"1992","journal-title":"Invest. New. Drugs"},{"key":"10.1016\/S0145-2126(99)00148-4_BIB7","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2307\/2281868","article-title":"Nonparametric observation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J. Am. Stat. Assoc."},{"issue":"6","key":"10.1016\/S0145-2126(99)00148-4_BIB8","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/hon.2900100603","article-title":"Mitoxantrone and intermediate-dose cytosine arabinoside for poor-risk acute leukemias: response to treatment and factors influencing outcome","volume":"10","author":"Sierra","year":"1992","journal-title":"Hematol. Oncol."},{"key":"10.1016\/S0145-2126(99)00148-4_BIB9","series-title":"Cancer Cytogenetics","author":"Heim","year":"1987"},{"issue":"11","key":"10.1016\/S0145-2126(99)00148-4_BIB10","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1182\/blood.V91.11.3995","article-title":"Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemia","volume":"91","author":"Faderl","year":"1998","journal-title":"Blood"},{"issue":"12","key":"10.1016\/S0145-2126(99)00148-4_BIB11","first-page":"2118","article-title":"Expression of myeloid antigens by blast cells in acute lymphoblastic leukemia of adults: the Southwest Oncology Group experience","volume":"8","author":"Boldt","year":"1994","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/S0145-2126(99)00148-4_BIB12","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1600-0609.1990.tb00386.x","article-title":"High-dose cytosine arabinoside and mitoxantrone in previously-treated acute leukemia patients","volume":"44","author":"Lejeune","year":"1990","journal-title":"Eur. J. Haematol."},{"issue":"9","key":"10.1016\/S0145-2126(99)00148-4_BIB13","first-page":"637","article-title":"Treatment of refractory acute lymphoblastic leukemia in adults with high dose cytosine arabinoside and mitoxantrone (HAM)","volume":"4","author":"Hiddemann","year":"1990","journal-title":"Leukemia"},{"key":"10.1016\/S0145-2126(99)00148-4_BIB14","first-page":"73","article-title":"High-dose cytosine arabinoside in combination with mitoxantrone for the treatment of refractory acute myeloid and lymphoblastic leukemia","volume":"14 (2 Suppl.1)","author":"Hiddemann","year":"1987","journal-title":"Semin. Oncol."},{"issue":"4","key":"10.1016\/S0145-2126(99)00148-4_BIB15","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1182\/blood.V79.4.876.bloodjournal794876","article-title":"Intensive chemotherapy with mitoxantrone and high-dose cytosine arabinoside followed by granulocyte-macrophage colony-stimulating factor in the treatment of patients with acute lymphocytic leukemia","volume":"79","author":"Kantarjian","year":"1992","journal-title":"Blood"},{"issue":"3\u20134","key":"10.1016\/S0145-2126(99)00148-4_BIB16","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3109\/10428199609051624","article-title":"Treatment of adult patients with acute lymphocytic leukemia in relapse","volume":"20","author":"Mazza","year":"1996","journal-title":"Leuk. Lymph."},{"issue":"9","key":"10.1016\/S0145-2126(99)00148-4_BIB17","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1200\/JCO.1996.14.9.2480","article-title":"Cytarabine with high-dose mitoxantrone induces rapid complete remissions in adult acute lymphoblastic leukemia without the use of vincristine or prednisone","volume":"14","author":"Weiss","year":"1996","journal-title":"J. Clin. Oncol."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212699001484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212699001484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T17:15:59Z","timestamp":1580231759000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212699001484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,3]]}},"alternative-id":["S0145212699001484"],"URL":"https:\/\/doi.org\/10.1016\/s0145-2126(99)00148-4","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2000,3]]}}}